Hospital Drug Discount Transparency Bill Faces Heavy ‘Lift’ In Congress
This article was originally published in The Pink Sheet Daily
Executive Summary
But biopharma industry can help drive reform of 340B discounts by emphasizing how it might improve pricing, Rep. Chris Collins, R-NY, suggests.